Recruitment

Recruitment Status
Withdrawn
Estimated Enrollment
40

Summary

Conditions
  • Metastatic Pancreatic Adenocarcinoma
  • Metastatic Pancreatic Cancer
  • Pancreatic Cancer
Type
Interventional
Phase
Phase 1
Design
Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT01510561
Collaborators
Not Provided
Investigators
Study Chair: William A Wegener, MD, PhD Gilead Sciences